-
effectivehealthcare-admin.ahrq.gov/products/coronary-stents-outcomes/research
January 01, 2020 - resulted in release of two special FDA advisories in 2006, 7,8 as well as subsequent studies refining event … In the rare event that a single ACC-NCDR® record could be matched with multiple Medicare records using … Death was the only event defined both during the index PCI procedure (using ACC-NCDR® information) and … rate of repeat revascularization in our population (24%) may be due to not censoring patients after an event … Unadjusted and adjusted results from time-to-event analyses for prespecified endpoints.
-
effectivehealthcare-admin.ahrq.gov/products/renal-update/research
January 01, 2020 - Skip to main content
An official website of the Department of Health & Human Services
Careers
Contact Us
Español
FAQs
Effective Health Care Program
Powered by the Evidence-based Practice Centers
…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/cer-239-acute-migraine-evidence-summary.pdf
December 01, 2020 - Evidence Summary for CER 239: Acute Treatments for Episodic Migraine
Comparative Effectiveness Review
Number 239
Acute Treatments for Episodic Migraine
Evidence Summary
Main Points
• Compared with placebo, treatments such as triptans, NSAIDs (nonsteroidal anti-
inflammatory drugs), dihydroergotamine, antieme…
-
effectivehealthcare-admin.ahrq.gov/products/asthma-immunotherapy/research-protocol
April 01, 2021 - We will also review the FDA Adverse Event Reporting System (FAERS). … to judge the likelihood that the intervention was causally related to the observed serious adverse event … Summary of Protocol Amendments
In the event of protocol amendments, the date of each amendment will … (McGraw Hill Concise Dictionary of Modern Medicine, 2002)
An adverse event is any undesirable experience … (Food and Drug Administration, 2009)
Serious adverse events (SAE): The event is serious and should
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/osteoporosis-bone-fracture_disposition-comments.pdf
March 01, 2012 - Peer Reviewer
7
Methods:
Chapter 2
It is fine to choose OR for rare event; however, the report … has
been using both RR and OR and in some cases, the event is
not very rare. … For adverse event, test, and exploration (when there are
enough number of studies) of heterogeneity … Designating
a hot flash as a cardiac event of any severity is misleading. … Some RRs are quite high, but the event is
quite rare.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/thromboembolism-update-executive-170622.pdf
June 01, 2017 - • In THR, LMWH has lower VTE and
adverse event risks than unfractionated
heparin; LMWH and aspirin … One NRCS had high risk of bias for adverse event
reporting and one was unclear. … Event rates were low for all participants (2% in both
the desirudin and the enoxaparin arms). … Only about half of studies
reported major bleeding, the adverse event of greatest
concern for most … This review made no assumptions about unreported event
rates.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/thromboembolism-update-executive-170622.pdf
June 01, 2017 - • In THR, LMWH has lower VTE and
adverse event risks than unfractionated
heparin; LMWH and aspirin … One NRCS had high risk of bias for adverse event
reporting and one was unclear. … Event rates were low for all participants (2% in both
the desirudin and the enoxaparin arms). … Only about half of studies
reported major bleeding, the adverse event of greatest
concern for most … This review made no assumptions about unreported event
rates.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/module_iv1.ppt
October 31, 2011 - Done effectively, facilitation is not a one-time event that occurs while someone leads a meeting or discussion … occur during scheduled meetings
Module IV Quiz:
Question 2: ANSWER
Facilitation is:
A one-time event … dynamics and processes
A superfluous skill
Module IV Quiz:
Question 3:
Facilitation is:
A one-time event
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/vaccine-safety_executive.pdf
January 01, 2020 - Case-control studies compare
people who have a disease or adverse event (“cases”)
with people who do … not have the disease or event
(“controls”) and look back retrospectively to compare
exposure to vaccine … in each group to determine the
relationship between the vaccine and the disease/
event.13,14
aLevel … SCCSs compare
outcome event rates during times when a person is
exposed (postvaccination) with those … Odds ratios could be calculated
for each event reported in each trial and postlicensure
study and,
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-2007_executive.pdf
January 01, 2007 - This may reflect low event rates among
otherwise healthy patients and relatively few studies with
extended
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_appendixes-2007.pdf
January 01, 2007 - , blood pressure; CHF, congestive heart failure; CKD, chronic kidney disease;
CVA, cerebrovascular event … treatment, or kidney function worsening (by GFR, SCr, or dialysis), or atherosclerotic cardiovascular event … unexpanded
stent 0.8%
Rocha-
Singh
200565
208
(208)
Angioplasty
stent
placement
Major vascular event … In-hospital 2.4%
Out of hospital up to
2 yr 2.9%
Cerebrovascular
accident 0%
Major embolic
event … 50% 100 Ostial: nd 3.5 yr 68% (3 yr) 59% (5 yr) C
Retro 51 44% (100) 1984-2004 0-17 yr CKD event
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/incident-user-design_research.pdf
May 01, 2012 - , an intervention’s benefits may require an induction period of months or years to
reduce clinical event … effectiveness evidence for another reason:
accurate reflections of the induction period or time-to-event … incident use of an intervention and its alternative, investigators can compare
cohorts’ times until event … than older drugs
because their apparent rate would be lower; investigators would observe a higher event … Studies that opt for
(event) risk scores instead of propensity scores to control confounding would also
-
effectivehealthcare-admin.ahrq.gov/products/epilepsy-medicine/research
December 01, 2019 - Skip to main content
An official website of the Department of Health & Human Services
Careers
Contact Us
Español
FAQs
Effective Health Care Program
Powered by the Evidence-based Practice Centers
…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/vaccine-safety_disposition-comments.pdf
January 01, 2020 - TEP # 1 Introduction—
Page 3 lines 11-
13
Change to “..the Vaccine Adverse Event Reporting System … It
is also possible to have high or moderate
strength of evidence for an extremely rare
adverse event … Similarly, event severity
was poorly described. … In many cases, the objective frequency
of an event is described poorly, or not at all. … An
understanding of the severity of an adverse event is
necessary for decision-makers to determine
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-257-antenatal-care-evidence-summary.pdf
June 01, 2022 - supportive
management, without which they expressed fears about repercussions from management
in the event … of a rare adverse event associated with maternity care.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-2007_research-2007-1.pdf
January 01, 2007 - • Safety (focusing on serious adverse event rates, overall adverse event rates, and withdrawals … Key Points
• Cough was modestly more frequently observed as an adverse event in groups treated with … However, the nature of serious adverse event reporting was
inconsistent, and rates of serious adverse … Depending on the definition used, adverse event rates ranged from 0 to 100
percent (median 32 percent … The one adverse event for which significant differential effects were apparent is cough.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/recombinant-factor-viia_clinician.pdf
October 01, 2010 - In-Hospital, Off-Label
Uses for rFVIIa1 Evidence on Benefits vs. Usual Care Evidence on Harms vs. Usual Care
Spontaneous
intracranial
hemorrhage*
No effect on mortality or functional status. ���
Attenuation of hematoma expansion. ���
Increased risk for arterial thromboembolic
events, particularly at doses >40 …
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/vte-protocol-8-4-10.pdf
February 01, 2008 - observational studies which compare
pharmacologic VTE prophylaxis methods will be used to report VTE event … Baseline risk of bleeding will be summarized using event rates from trials or large
observational studies … KQ 3
will be addressed by qualitatively reporting event rates of both asymptomatic and
symptomatic … the change scores will be calculated using the method proposed by Follman
and colleagues.10 In the event … Summary of Protocol Amendments
In the event of protocol amendments, the date of each amendment will
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/blood-clots-hip-knee-surgery_research-protocol.pdf
February 01, 2008 - observational studies which compare
pharmacologic VTE prophylaxis methods will be used to report VTE event … Baseline risk of bleeding will be summarized using event rates from trials or large
observational studies … KQ 3
will be addressed by qualitatively reporting event rates of both asymptomatic and
symptomatic … the change scores will be calculated using the method proposed by Follman
and colleagues.10 In the event … Summary of Protocol Amendments
In the event of protocol amendments, the date of each amendment will
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/asthma-immunotherapy_research-protocol.pdf
September 14, 2016 - We will also review the FDA Adverse Event
Reporting System (FAERS). … to judge the
likelihood that the intervention was causally related to the observed serious adverse event … Summary of Protocol Amendments
In the event of protocol amendments, the date of each amendment will … (McGraw Hill Concise Dictionary of Modern Medicine, 2002)
b) An adverse event is any undesirable experience … http://www.fda.gov/Safety/MedWatch/HowToReport/ucm053087.htm )
c) Serious adverse events (SAE): The event